vs

Side-by-side financial comparison of BioNTech SE (BNTX) and VISTEON CORP (VC). Click either name above to swap in a different company.

BioNTech SE is the larger business by last-quarter revenue ($1.5B vs $948.0M, roughly 1.6× VISTEON CORP). VISTEON CORP runs the higher net margin — 7.8% vs -1.9%, a 9.7% gap on every dollar of revenue.

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.

Visteon Corporation (VC) is an American global automotive electronics supplier based in Van Buren Township, Michigan. Visteon designs, engineers, and manufactures vehicle cockpit electronics products, connected car services and electrification products for its customers, which include nearly all of the major automakers worldwide.

BNTX vs VC — Head-to-Head

Bigger by revenue
BNTX
BNTX
1.6× larger
BNTX
$1.5B
$948.0M
VC
Higher net margin
VC
VC
9.7% more per $
VC
7.8%
-1.9%
BNTX

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BNTX
BNTX
VC
VC
Revenue
$1.5B
$948.0M
Net Profit
$-28.7M
$74.0M
Gross Margin
12.9%
Operating Margin
-3.1%
6.9%
Net Margin
-1.9%
7.8%
Revenue YoY
1.0%
Net Profit YoY
-40.8%
EPS (diluted)
$2.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BNTX
BNTX
VC
VC
Q4 25
$948.0M
Q3 25
$1.5B
$917.0M
Q2 25
$260.8M
$969.0M
Q1 25
$934.0M
Q4 24
$939.0M
Q3 24
$1.2B
$980.0M
Q2 24
$1.0B
Q1 24
$933.0M
Net Profit
BNTX
BNTX
VC
VC
Q4 25
$74.0M
Q3 25
$-28.7M
$-11.0M
Q2 25
$-386.6M
$71.0M
Q1 25
$67.0M
Q4 24
$125.0M
Q3 24
$198.1M
$40.0M
Q2 24
$83.0M
Q1 24
$48.0M
Gross Margin
BNTX
BNTX
VC
VC
Q4 25
12.9%
Q3 25
14.3%
Q2 25
14.6%
Q1 25
14.8%
Q4 24
14.3%
Q3 24
13.4%
Q2 24
14.5%
Q1 24
12.8%
Operating Margin
BNTX
BNTX
VC
VC
Q4 25
6.9%
Q3 25
-3.1%
8.8%
Q2 25
-192.1%
10.0%
Q1 25
10.2%
Q4 24
8.9%
Q3 24
0.8%
5.2%
Q2 24
9.9%
Q1 24
6.8%
Net Margin
BNTX
BNTX
VC
VC
Q4 25
7.8%
Q3 25
-1.9%
-1.2%
Q2 25
-148.2%
7.3%
Q1 25
7.2%
Q4 24
13.3%
Q3 24
15.9%
4.1%
Q2 24
8.2%
Q1 24
5.1%
EPS (diluted)
BNTX
BNTX
VC
VC
Q4 25
$2.67
Q3 25
$-0.40
Q2 25
$2.57
Q1 25
$2.44
Q4 24
$4.50
Q3 24
$1.43
Q2 24
$2.97
Q1 24
$1.71

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BNTX
BNTX
VC
VC
Cash + ST InvestmentsLiquidity on hand
$771.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
Total Assets
$3.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BNTX
BNTX
VC
VC
Q4 25
$771.0M
Q3 25
$762.0M
Q2 25
$668.0M
Q1 25
$655.0M
Q4 24
$623.0M
Q3 24
$550.0M
Q2 24
$505.0M
Q1 24
$504.0M
Stockholders' Equity
BNTX
BNTX
VC
VC
Q4 25
$1.6B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$1.4B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.2B
Q1 24
$1.1B
Total Assets
BNTX
BNTX
VC
VC
Q4 25
$3.4B
Q3 25
$3.3B
Q2 25
$3.3B
Q1 25
$3.1B
Q4 24
$3.0B
Q3 24
$3.0B
Q2 24
$2.8B
Q1 24
$2.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BNTX
BNTX
VC
VC
Operating Cash FlowLast quarter
$118.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.59×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BNTX
BNTX
VC
VC
Q4 25
$118.0M
Q3 25
$127.0M
Q2 25
$95.0M
Q1 25
$70.0M
Q4 24
$203.0M
Q3 24
$98.0M
Q2 24
$57.0M
Q1 24
$69.0M
Cash Conversion
BNTX
BNTX
VC
VC
Q4 25
1.59×
Q3 25
Q2 25
1.34×
Q1 25
1.04×
Q4 24
1.62×
Q3 24
2.45×
Q2 24
0.69×
Q1 24
1.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BNTX
BNTX

Segment breakdown not available.

VC
VC

Audioandinfotainment$508.0M54%
Informationdisplays$428.0M45%

Related Comparisons